Guardian Australia · GSK

GSK reports promising early results in ovarian and womb cancer drug trial

· By Juliakollewe
Story summary

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug

Read at Guardian Australia

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.